Start here if you're new
what it is
Ecovyst makes catalysts and sulfuric acid recycling systems for refineries and other industrial plants.
how it gets paid
Last year Ecovyst made $724M in revenue. EcoServices was the main engine at $0.304B, or 42% of sales.
why it's growing
Revenue grew 262.8% last year. Revenue was $199M, up 34% vs. prior year, and gross margin was 23.4%.
what just happened
Ecovyst printed $0.28 adjusted EPS versus $0.17 expected, while EDGAR still shows $0.05 GAAP EPS.
At a glance
B+ balance sheet — decent shape, but not bulletproof
15/100 earnings predictability — expect surprises
18.6x trailing p/e — priced about right
7.5% return on capital — nothing to write home about
xvary composite: 53/100 — below average
What they do
Ecovyst makes catalysts and sulfuric acid recycling systems for refineries and other industrial plants.
Your moat is plumbing, not fame. Ecovyst's sulfuric acid regeneration gets baked into industrial sites, and 10 customers still drove about 60% of 2024 sales. Switching costs (leaving a supplier is expensive and risky) keep your customer list sticky.
How they make money
$724M
annual revenue · their business grew +262.8% last year
EcoServices
$0.304B
Advanced Silicas
$0.253B
Zeolyst JV
$0.167B
The products that matter
recycles spent industrial acid
Sulfuric Acid Regeneration
core to the remaining company
this is the center of gravity now. The page does not give you a neat segment split, so we will not pretend it does. What you do know is that the remaining business has to support the post-sale case largely through this service model.
core
portfolio move that changed the model
Advanced Materials & Catalysts divestiture
$530M cash proceeds
this is not a product line you are buying anymore. It is the event that reset the story. The sale removed revenue, added cash, and told you management prefers focus and debt cleanup over complexity.
reset
supports the remaining revenue base
Virgin Sulfuric Acid Sales
part of the $640M 2026 plan
this business helps fill out the smaller post-sale base. The data here is thin. That matters. When disclosures are thin, your confidence should be too.
supporting revenue
Key numbers
60%
sales concentration
Ten customers drive about 60% of 2024 sales. That means you do not own a diversified machine; you own a relationship portfolio.
$0.846B
long debt
The company still carries $846M of long-term debt. That leaves less room if growth misses.
9.0%
operating margin
Ecovyst keeps 9.0% of sales after operating costs. That is slim air in a chemicals business.
7.5%
return on capital
The business earns 7.5% on the money tied up in it. That is fine, not spectacular.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- price stability 30 / 100
- long-term debt $846M (39% of capital)
- net profit margin 13.4% — keeps 13 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in ECVT 3 years ago → it's now worth $10,250.
The index would have given you $13,880.
source: institutional data · total return
What just happened
beat estimates
Ecovyst printed $0.28 adjusted EPS versus $0.17 expected, while EDGAR still shows $0.05 GAAP EPS.
Revenue was $199M, up 34% vs. prior year, and gross margin was 23.4%. The beat lives on an adjusted scoreboard, which is how you end up with two truths in one quarter.
$199M
revenue
$0.05
eps
23.4%
gross margin
adjusted EPS beat
The $0.28 adjusted EPS print mattered because it beat $0.17 by $0.11 even as GAAP EPS stayed at $0.05.
-
ecovyst has lowered its financial leverage.on january 2nd, the company sold its advanced materials & catalysts (am&c) segment to technip industries, netting $530 million in cash proceeds. ecovyst is using these funds to pay down much of its long-term debt, thus reducing its interest expense.
-
the debt reduction should allow the company to operate on a more efficient platform.it should also permit more share buybacks at the currently low stock price, enhancing the per-share profit numbers. in addition, it ought to provide ecvt with a greater cash cushion to help it navigate unforeseen work stoppages and plant outages, as well as erratic client demand patterns.
-
the am&c sale has resulted in a smaller, more focused company.the remaining businesses are composed of virgin sulfuric acid sales and acid regeneration services, and ought to generate 2026 revenue of $640 million.
-
this compares to our 2025 sales estimate of $740 million.the more streamlined company has become leaner, which is liable to result in a greater likelihood of quarterly profits.
-
this factor, combined with a healthier balance sheet, should aid stock price resiliency.note that the growth consistency rating over the last few years has been at a rock-bottom 5 (out of 100).
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the main risk is that Ecovyst just traded diversification for fragility. After the sale, almost the entire equity story rests on a smaller sulfuric-acid-centered business hitting a $640M revenue base while debt cleanup actually shows up in reported results.
med
the smaller base misses early
management now points to about $640M of 2026 revenue. That is the new floor under the thesis. If the first few post-sale quarters run below that pace, investors stop telling a simplification story and start telling a shrinkage story.
the market is already being asked to value a smaller company at roughly 25x fy2026 EPS. Miss the first clean setup, and that multiple usually compresses before management finishes the conference call.
med
debt relief looks smaller in the income statement than it did in the press release
$530M sounds decisive because it is. But long-term debt was $846M. The real test is whether the 26.0% operating margin stops collapsing into a 9.3% net margin. If that gap stays wide, you did not really buy yourself a new earnings profile.
this is the balance-sheet version of "show me." Lower debt has to show up in cleaner earnings, not just a nicer slide deck.
med
industrial demand rolls over at the wrong time
Ecovyst serves refining and other heavy industrial customers. In plain English: when activity softens, volumes usually follow. This is not a business insulated by consumer subscriptions or recurring software fees.
a cyclical wobble hurts more after a portfolio sale because there are fewer moving parts left to offset it.
med
the stock is priced for improvement before improvement is stable
15/100 earnings predictability and 30/100 price stability tell you the line has not been smooth. Yet the stock sits near the top of its $5–$11 range and trades around 25x fy2026 EPS.
if you do not get cleaner quarters soon, you can lose on the multiple even if the business stays merely okay.
Here is the whole thing in one sentence: if the post-sale company does not quickly look cleaner, steadier, and less burdened by debt, then you are left owning a smaller cyclical industrial name at a not-small-cap bargain multiple.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
the first few quarters of the smaller Ecovyst
$640M a year translates to roughly $160M a quarter. You do not need perfect precision here. You need evidence that the remaining business can clear that bar without drama.
balance sheet
whether the $530M sale actually changes the math
watch long-term debt and the gap between operating margin and net margin. The cash proceeds only matter if reported earnings start keeping more of what operations produce.
industry demand
refinery and heavy industrial activity
this business follows industrial throughput more than consumer sentiment. If plant activity cools, Ecovyst usually feels it before the stock finishes telling itself a cleaner-story narrative.
quality of earnings
whether predictability improves from 15/100
here's the thing: a focused company is supposed to produce cleaner numbers. If predictability stays ugly, the market keeps treating this as a trade, not a trusted operator.
Analyst rankings
short-term outlook
average
momentum score 3 — in human-speak, analysts see a wait-and-see stock, not a clear short-term edge.
risk profile
average
stability score 3 — this is not a fortress, but it also is not a balance-sheet fire drill.
chart momentum
average
technical score 3 — the chart has improved, but after the run from $5 to $11 the market is asking for proof, not promises.
earnings predictability
15 / 100
low predictability — if you own ECVT, expect the quarterly line to be rougher than the annual thesis deck.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 89 buyers vs. 86 sellers in 3q2025. total institutional holdings: 0.1B shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$5
$14
$11
current price
$9
target midpoint · 19% from current · 3-5yr high: $18 (+60% · 13% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive